Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction

Biochim Biophys Acta. 2014 Oct;1843(10):2270-81. doi: 10.1016/j.bbamcr.2014.03.021. Epub 2014 Apr 1.

Abstract

VDAC1, an outer mitochondrial membrane (OMM) protein, is crucial for regulating mitochondrial metabolic and energetic functions and acts as a convergence point for various cell survival and death signals. VDAC1 is also a key player in apoptosis, involved in cytochrome c (Cyto c) release and interactions with anti-apoptotic proteins. Recently, we demonstrated that various pro-apoptotic agents induce VDAC1 oligomerization and proposed that a channel formed by VDAC1 oligomers mediates cytochrome c release. As VDAC1 transports Ca(2+) across the OMM and because Ca(2+) has been implicated in apoptosis induction, we addressed the relationship between cytosolic Ca(2+) levels ([Ca(2)(+)]i), VDAC1 oligomerization and apoptosis induction. We demonstrate that different apoptosis inducers elevate cytosolic Ca(2+) and induce VDAC1 over-expression. Direct elevation of [Ca(2+)]i by the Ca(2+)-mobilizing agents A23187, ionomycin and thapsigargin also resulted in VDAC1 over-expression, VDAC1 oligomerization and apoptosis. In contrast, decreasing [Ca(2+)]i using the cell-permeable Ca(2+)-chelating reagent BAPTA-AM inhibited VDAC1 over-expression, VDAC1 oligomerization and apoptosis. Correlation between the increase in VDAC1 levels and oligomerization, [Ca(2+)]i levels and apoptosis induction, as induced by H2O2 or As2O3, was also obtained. On the other hand, cells transfected to overexpress VDAC1 presented Ca(2+)-independent VDAC1 oligomerization, cytochrome c release and apoptosis, suggesting that [Ca(2+)]i elevation is not a pre-requisite for apoptosis induction when VDAC1 is over-expressed. The results suggest that Ca(2+) promotes VDAC1 over-expression by an as yet unknown signaling pathway, leading to VDAC1 oligomerization, ultimately resulting in apoptosis. These findings provide a new insight into the mechanism of action of existing anti-cancer drugs involving induction of VDAC1 over-expression as a mechanism for inducing apoptosis. This article is part of a Special Issue entitled: Calcium Signaling in Health and Disease. Guest Editors: Geert Bultynck, Jacques Haiech, Claus W. Heizmann, Joachim Krebs, and Marc Moreau.

Keywords: Apoptosis; Calcium; Oligomerization; VDAC1 over-expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcimycin / pharmacology
  • Calcium / metabolism*
  • Calcium Ionophores / pharmacology
  • Calcium Signaling*
  • Cell Death / drug effects
  • Cell Line, Tumor
  • Cell Survival
  • Chelating Agents / pharmacology
  • Cytochromes c / metabolism
  • Egtazic Acid / analogs & derivatives
  • Egtazic Acid / pharmacology
  • Gene Expression Regulation*
  • Humans
  • Hydrogen Peroxide / pharmacology
  • Ionomycin / pharmacology
  • Mitochondria / drug effects
  • Mitochondria / genetics
  • Mitochondria / metabolism*
  • Mitochondrial Membranes / drug effects
  • Mitochondrial Membranes / metabolism*
  • Protein Multimerization
  • Thapsigargin / pharmacology
  • Voltage-Dependent Anion Channel 1 / genetics*
  • Voltage-Dependent Anion Channel 1 / metabolism

Substances

  • Calcium Ionophores
  • Chelating Agents
  • VDAC1 protein, human
  • 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester
  • Calcimycin
  • Egtazic Acid
  • Ionomycin
  • Thapsigargin
  • Cytochromes c
  • Hydrogen Peroxide
  • Voltage-Dependent Anion Channel 1
  • Calcium